|
|
Volumn 8, Issue 1-2, 2010, Pages 44-94
|
|
List of drugs in development for neurodegenerative diseases: Update June 2010
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
11C 6 ME BTA 1;
11C AZD 2184;
11C AZD 2995;
11C GSK 21508;
11C GSK 215083;
11C PBR 28;
123I IMPY;
123I MNI 330;
18F AV 133;
18F FDDNP;
18F NST ML 10;
249320;
2B3 201;
4 PBA;
586529;
AAB 002;
AAD 2004;
AB 087;
ANTIDEPRESSANT AGENT;
ANTIPARKINSON AGENT;
CONTRAST MEDIUM;
EPIGALLOCATECHIN GALLATE;
MONOCLONAL ANTIBODY;
NEUROPROTECTIVE AGENT;
NOOTROPIC AGENT;
NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;
PHENSERINE;
SEROTONIN 2C AGONIST;
TROPANTIOL 99M TC;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
CLINICAL TRIAL;
DEGENERATIVE DISEASE;
HUMAN;
INFORMATION;
INTERNET;
PRIORITY JOURNAL;
REVIEW;
DRUG INDUSTRY;
NEURODEGENERATIVE DISEASES;
PSYCHOTROPIC DRUGS;
RESEARCH;
|
|
EID: 78650170567
PISSN: 16602854
EISSN: 16602862
Source Type: Journal
DOI: 10.1159/000318238 Document Type: Review |
|
Times cited : (10)
|
|
References (0)
|
